Log In
BCIQ
Print this Print this
 

Ularitide (ULA01)

  Manage Alerts
Collapse Summary General Information
Company Cardiorentis AG
DescriptionIV infusion of a chemically synthesized form of the naturally occurring natriuretic peptide urodilatin
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationHeart failure
Indication DetailsTreat acute decompensated heart failure (ADHF); Treat acute heart failure (AHF)
Regulatory Designation U.S. - Fast Track (Treat acute decompensated heart failure (ADHF));
U.S. - Fast Track (Treat acute heart failure (AHF))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/16/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today